Health
Pfizer to submit emergence use approval request for Covid-19 vaccine again: Spokesperson – Deccan Herald
After reports of Pfizer withdrawing its application for emergency use authorisation of its Covid-19 vaccine in India, the company spokesperson said that it will resubmit…
Pfizer Inc said on Friday it had withdrawn an application for emergency-use authorisation of its Covid-19 vaccine in India, after failing to meet the drug regulator’s demand for a local safety and immunogenicity study.
The decision means the vaccine will not be available for sale in the world’s two most populous countries, India and China, in the near future. Both countries are running their immunisation campaigns using other products.
Unlike other companies conducting small studies in India for…
-
General15 hours ago‘We are here for you’: PM to bring help to flood zones
-
General14 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Noosa News21 hours agoStudents say new facility would be better in rural areas of Queensland
-
Business12 hours ago10 ASX shares to buy after the market selloff